• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synthesis of multivalent sialyllactosamine-carrying glyco-nanoparticles with high affinity to the human influenza virus hemagglutinin

tetano

Editor, Senior Moderator
Carbohydr Polym. 2016 Nov 20;153:96-104. doi: 10.1016/j.carbpol.2016.07.083. Epub 2016 Jul 20.
[h=1]Synthesis of multivalent sialyllactosamine-carrying glyco-nanoparticles with high affinity to the human influenza virus hemagglutinin.[/h] Ogata M[SUP]1[/SUP], Umemura S[SUP]2[/SUP], Sugiyama N[SUP]2[/SUP], Kuwano N[SUP]3[/SUP], Koizumi A[SUP]3[/SUP], Sawada T[SUP]4[/SUP], Yanase M[SUP]5[/SUP], Takaha T[SUP]5[/SUP], Kadokawa J[SUP]6[/SUP], Usui T[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A series of multivalent sialoglyco-conjugated nanoparticles were efficiently synthesized by using highly-branched α-glucuronic acid-linked cyclic dextrins (GlcA-HBCD) as a backbone. The sialoglycoside-moieties, with varying degrees of substitution, could be incorporated onto the preformed nanoparticles. These synthesized particles, which are highly soluble in aqueous solution, were shown to have a spherical nanostructure with a diameter of approximately 15nm. The interactions of the sialoglyco-nanoparticles (Neu5Acα2,6LacNAc-GlcA-HBCDs) with human influenza virus strain A/Beijing/262/95 (H1N1) were investigated using a hemagglutination inhibition assay. The sialoglyco-nanoparticle, in which the number of sialic acid substitution is 30, acted as a powerful inhibitor of virus binding activity. We show that both distance and multiplicity of effective ligand-virus formation play important roles in enhancing viral inhibition. Our results indicate that the GlcA-HBCD backbone can be used as a novel spherical nanocluster material for preparing a variety of glyco-nanoparticles to facilitate molecular recognition.
Copyright ? 2016 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Carbohydrate; Cluster effect; Influenza virus; Multivalency; Nanoparticle

PMID: 27561476 DOI: 10.1016/j.carbpol.2016.07.083
[PubMed - in process]
 
Back
Top Bottom